Candy-coated Lollylab checks saliva for medication
What if checking medication levels were as simple as enjoying a lollipop? A candy-coated device, called Lollylab, could provide the answer. In ACS Sensors, researchers describe how the… read more.
What if checking medication levels were as simple as enjoying a lollipop? A candy-coated device, called Lollylab, could provide the answer. In ACS Sensors, researchers describe how the… read more.
Novo announced new real-world data from the OCTANE study, an analysis of de-identified data from the Ro telehealth platform. In the study, adults with overweight or obesity who… read more.
Roche announced that the FDA has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of stage… read more.
Pacira BioSciences, Inc. announced a strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets. Through this partnership, Molteni Farmaceutici will receive… read more.
Three out of England’s seven NHS genetics laboratories are failing to routinely share vital information about genetic variants in public databases that helps patients with rare diseases access… read more.
Several reforms to EU chemicals policy and legislation have been introduced in recent years, with the aim of promoting the green transformation. Many of these reforms also affect… read more.
Eli Lilly and Company announced detailed results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo (orforglipron) compared to titrated insulin glargine in adults… read more.
Mirum Pharmaceuticals, Inc. announced topline results from the Phase 3 EXPAND study evaluating LIVMARLI (maralixibat) for the treatment of cholestatic pruritus in patients aged 6 months or older… read more.
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related outcomes in comorbid conditions such as chronic kidney disease (CKD), obstructive… read more.
Children living with sickle cell anaemia have no higher incidence of clinically diagnosed infections when treated with hydroxyurea. New research shows the efficacy and safety of hydroxyurea treatment… read more.
Pharmacies across the United States continue to close at a rapid rate, leaving millions of Americans in “pharmacy deserts,” where they lack convenient and reasonable access to the… read more.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible…. read more.